Here’s the short answer: CBL (cannabicyclol) can be lawful to buy and sell in the United States when it is derived from federally legal hemp and the finished product contains no more than 0.3% delta-9 THC by dry weight. That follows the 2018 Farm Bill’s definition of hemp and hemp “derivatives” and “extracts.” However, legality also depends on how a product is marketed and where you live, because federal food-and-drug rules and rapidly changing state laws still apply.

Federal baseline. The Farm Bill removed “hemp” (and its derivatives) from the federal Controlled Substances Act if the delta-9 THC concentration stays at or below 0.3%. CBL itself is not named on DEA’s alphabetical list of scheduled substances, which supports the view that hemp-derived CBL—without excess THC—is not a controlled substance under federal law.

FDA rules still matter. Even when a cannabinoid is lawful under the CSA, products containing it must still comply with the Federal Food, Drug, and Cosmetic Act. FDA has repeatedly emphasized that cannabinoids cannot be added to conventional foods or marketed as dietary supplements, and it continues to issue warning letters for unapproved health claims and non-compliant products. Any CBL product making disease or structure/function claims, or sold as a supplement or food without an approved pathway, risks enforcement.

State-by-state variation. Many states have adopted age limits, potency caps, or outright prohibitions on certain hemp-derived cannabinoids, largely in response to intoxicating variants (e.g., delta-8 THC). Some state actions sweep more broadly and can affect the sale or form factors of any hemp cannabinoid, regardless of intoxication. Texas, for example, has recently moved to tighten rules around hemp products and THC-A, and other states maintain complex beverage or retail restrictions. Always check your state’s latest rules before buying or selling CBL products.

So, is CBL legal?

• Often yes, federally—if hemp-derived and ≤0.3% delta-9 THC.
• Not necessarily in every state or product category. Labeling, age-gating, product type (food, beverage, supplement), and local definitions can change the answer.

Consumer concerns even when legal.

1. Label accuracy and quality. Studies and FDA enforcement show frequent mislabeling and contamination risks (e.g., pesticides, heavy metals) in cannabinoid products. Buy only items with recent ISO-accredited third-party lab reports (COAs).
2. Unapproved claims. Be skeptical of products touting therapeutic benefits; such claims can signal non-compliance and poor oversight.
3. Patchwork rules. What’s sold online may not be lawful to ship or possess in your state; retailers and consumers should verify local requirements, especially as legislatures continue to revise hemp laws.
4. Limited research. CBL is a minor, non-intoxicating cannabinoid formed through oxidation of CBC; human data are sparse, so start low and go slow, and discuss use with a clinician if you take other medications.

Bottom line: Hemp-derived CBL products with compliant THC limits are generally permissible at the federal level, but compliance with FDA rules and state law is essential. Check for a current COA, avoid medical-claim marketing, and confirm your state’s regulations before purchase.